Well I'm not totally oblivious to how it will behave considering phase 3 results should be ready Q2 2017. The only thing that will move it substantially is if they license some product and what are the odds of that before phase 3 is reached?
I have changed my sentiment to sell, but it is a 'great' stock for the future.
Good luck all, I hope it explodes this year, then I will look really like a fried fish.
Ann: Outcomes of DMX-200 pre-IND meeting with the FDA-DXB.AX, page-39
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
-0.035(6.42%) |
Mkt cap ! $280.3M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 54.0¢ | 50.0¢ | $1.454M | 2.822M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 544899 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 104681 | 4 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |